Beetham Thomas W. (CIK 0001741382)

Latest company ownership

KNSA - Kiniksa Pharmaceuticals International, plc
Role: EVP & Chief Legal Officer
Shares held
300,000
Last filed at
Feb 5, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
19,897
Last filed at
Dec 2, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
6,000
Last filed at
Sep 30, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 27, 2024 Sep 30, 2024 Viridian Therapeutics, Inc.\DE COO Buy 95.0 +5,000 500.00% ✗ $117.1K
Sep 16, 2021 Sep 20, 2021 Dianthus Therapeutics, Inc. /DE/ Officer Sell 26.3 -6,103 -30.52% ✗ $41.1K
Feb 3, 2021 Feb 5, 2021 Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer Sell 47.5 -2,477 -0.83% ✓ $54.7K
Jul 1, 2020 Jul 2, 2020 Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer Sell 7.5 -29,589 -100.00% ✓ $750.7K
Jun 10, 2020 Jun 12, 2020 Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer Sell 7.5 -13,752 -31.73% ✓ $344.8K
Apr 20, 2020 Apr 22, 2020 Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer Sell 7.5 -49,941 -62.80% ✓ $954K
Feb 14, 2020 Feb 19, 2020 Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer Sell 56.3 -59 -0.07% ✓ $1.1K